Biopharmaceutical manufacturers seek ways to more quickly and efficiently scale up their operations as well as maintain quality control processes when bringing new products to market. Automation is one place to help drive these improvements.
Emerson’s Mukta Sharma alerted me to a whitepaper, How to Simplify Your Pneumatic Valve Installation to Improve Your Drug Manufacturing Operation, which highlights the critical role that pneumatic valve systems play across the drug development lifecycle—from drug discovery and production, to packaging and utilities.
Key considerations for pneumatic valve systems, such as the AVENTICS Directional Control Valve Manifolds are that they:
…save space, meet process requirements and help you manage input/output (I/O) complexity through electronic marshalling. By addressing these three elements together, you can implement pneumatic valve manifolds into a process control architecture that is driven by a distributed control system (DCS) or programmable logic controller (PLC) on just one network.
Key requirements for modern pneumatic valve systems to support manufacturing flexibility and scale up:
- Are hygienic by design
- Optimize cabinet real estate
- Reduce I/O complexity
- Are designed for end users
- Reduce commissioning time
Download the whitepaper to learn more about these requirements to simplify and streamline your biopharmaceutical manufacturing operations.
Visit the AVENTICS section on Emerson.com for more on the pneumatic solutions including a broad portfolio of cylinders, valves, air preparation and pressure regulators. You can also connect and interact with other pneumatic experts in the Fluid Control & Pneumatics group in the Emerson Exchange 365 community.
